Evidence map›Paper›PMID 23575824›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.

Robert M Cohen, Kavon Rezai-Zadeh, Tara M Weitz, Altan Rentsendorj, David Gate, Inna Spivak, Yasmin Bholat, Vitaly Vasilevko, Charles G Glabe, Joshua J Breunig and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 315 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
315citing papers in PubMed, 1 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

315 citing papers in PubMed, 1 synthesis or guideline pooled it, 535 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Head-to-head comparison of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  5. International journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Stable neuronal representations underlie cognitive resilience to Alzheimer's disease pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Decoding the mechanisms of amyloid-β in synaptic toxicity.Journal of Alzheimer's disease : JAD · 2026
    Review
  17. Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  20. Aberrant Medial Prefrontal Cortex Activity and Flexible Behavior in the TgF344-AD Rat Model of Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article

255 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Robert M CohenDepartment of Psychiatry and Behavioral Neurosciences, S Mark Taper Imaging Center, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. robert.m.cohen@emory.edu
Kavon Rezai-Zadeh
Tara M Weitz
Altan Rentsendorj
David Gate
Inna Spivak
Yasmin Bholat
Vitaly Vasilevko
Charles G Glabe
Joshua J Breunig
Pasko Rakic
Hayk Davtyan
Michael G Agadjanyan
Vladimir Kepe
Jorge R Barrio
Serguei Bannykh
Christine A Szekely
Robert N Pechnick
Terrence Town
Regenerative Medicine Institute · MXUniversity of California, Irvine · USCedars-Sinai Medical Center · USImaging Center · USUniversity of California, Los Angeles · USYale University · US

Funding

RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
NEUROGENETIC PROCESSES IN THE FETAL BRAINR01NS014841 · NINDS · YALE UNIVERSITY · PI RAKIC, PASKO · 1985 to 2015
$10.4M
Training in the Neurobiology of Aging and Alzheimers DiseaseT32AG000096 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI VIVEK SWARUP, Craig E Stark · 1985 to 2026
$9.6M
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's RatsR01NS076794 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHANG, KAREN T, CHEN, JEANNIE · 2011 to 2021
$4.9M
Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseasR00AG029726 · NIA · CEDARS-SINAI MEDICAL CENTER · PI TOWN, TERRENCE C · 2008 to 2010
$790k
The Role of CD8+ Tcells in a Rat Model of Alzheimer's DiseaseR21AG033394 · NIA · CEDARS-SINAI MEDICAL CENTER · PI COHEN, ROBERT MARTIN · 2009 to 2010
$365k
NIA NIH HHS 1R21AG033394-01NIA NIH HHS 3R00AG029726-04S1NIA NIH HHS 5R00AG029726-03NIA NIH HHS 5R00AG029726-04NIA NIH HHS AG000096NIA NIH HHS R00 AG029726NIA NIH HHS R21 AG033394NIA NIH HHS T32 AG000096NIA NIH HHS U19 AG010483NINDS NIH HHS 1R01NS076794-01NINDS NIH HHS R01 NS014841NINDS NIH HHS R01 NS076794
6 · The paper itself

Abstract

Alzheimer's disease (AD) is hallmarked by amyloid plaques, neurofibrillary tangles, and widespread cortical neuronal loss (Selkoe, 2001). The "amyloid cascade hypothesis" posits that cerebral amyloid sets neurotoxic events into motion that precipitate Alzheimer dementia (Hardy and Allsop, 1991). Yet, faithful recapitulation of all AD features in widely used transgenic (Tg) mice engineered to overproduce Aβ peptides has been elusive. We have developed a Tg rat model (line TgF344-AD) expressing mutant human amyloid precursor protein (APPsw) and presenilin 1 (PS1ΔE9) genes, each independent causes of early-onset familial AD. TgF344-AD rats manifest age-dependent cerebral amyloidosis that precedes tauopathy, gliosis, apoptotic loss of neurons in the cerebral cortex and hippocampus, and cognitive disturbance. These results demonstrate progressive neurodegeneration of the Alzheimer type in these animals. The TgF344-AD rat fills a critical need for a next-generation animal model to enable basic and translational AD research.

Indexed as

Age FactorsAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsBehavior, AnimalCerebral Amyloid AngiopathyCerebral CortexCognition DisordersDisease Models, AnimalFemaleGliosisHippocampusHumansMaleNerve DegenerationAmyloid beta-PeptidesAmyloid beta-Protein PrecursorPresenilin-1tau Proteins

Identifiers

PMID23575824
PMCPMC3720142
OpenAlexW2166578434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.